✦ LIBER ✦

Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis

✍ Scribed by Richard Rauck; Ronald Rapoport; John Thipphawong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind study of OROS

✍ D. Taylor; M. Kutch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Efficacy and tolerability of OROS hydrom

✍ M. Hale; J. Patrick; S. Nalamachu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Safety and efficacy of once-daily hydrom

✍ U. Richarz; S. Waechter; R. Sabatowski; L. Szczepanski; H. Binsfeld 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Sustained Safety and Efficacy of Once-Da

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

A randomized, double-blind study of OROS

✍ M. Hale; R. Rauck; S. Li; M. Kutch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy and Safety of a Once-Daily Morp

✍ Jacques R. Caldwell; Ronald J. Rapoport; Jeffrey C. Davis; Howard L. Offenberg; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 306 KB